Eventide Asset Management, LLC 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 1:09 pm Sale | 2025-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Eventide Asset Management, LLC | 2,093,582 4.100% | -513,356 (-19.69%) | Filing |
| 2025-02-14 12:06 pm Purchase | 2024-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Eventide Asset Management, LLC | 2,606,938 5.430% | 386,938 (+17.43%) | Filing |
| 2024-11-14 12:25 pm Purchase | 2024-09-30 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Eventide Asset Management, LLC | 3,445,363 7.220% | 751,782 (+27.91%) | Filing |
| 2024-02-14 12:49 pm Purchase | 2023-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Eventide Asset Management, LLC | 2,693,581 5.780% | 636,581 (+30.95%) | Filing |
| 2023-02-14 1:34 pm Purchase | 2022-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Eventide Asset Management, LLC | 2,057,000 5.600% | 2,057,000 (New Position) | Filing |